Frontal Fibrosing Alopecia
July 2018
New to Finasteride? There is a guide in the encyclopedia. Read the guide → frontal fibrosing alopecia scarring alopecia postmenopausal women frontotemporal hairline recession eyebrow loss eyelash involvement body hair involvement non-inflammatory facial papules autoimmune factors hormonal factors trichoscopy 5-alpha-reductase inhibitors finasteride topical immunomodulators pimecrolimus FFA Propecia Elidel
Studysummary This study reported that prompt diagnosis and treatment with 5-alpha-reductase inhibitors and topical immunomodulators are key to mitigating the effects of frontal fibrosing alopecia and preventing permanent hair loss.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Frontal fibrosing alopecia (FFA) was a scarring alopecia primarily affecting postmenopausal women, with a mean onset age of 56 years. It involved progressive frontotemporal hairline recession and eyebrow loss, with severe cases showing eyelash or body hair involvement and non-inflammatory facial papules. The pathogenesis was unclear but likely involved autoimmune and hormonal factors. Diagnosis relied on clinical patterns and trichoscopy. No established therapy existed, but 5-alpha-reductase inhibitors like finasteride and topical immunomodulators like pimecrolimus showed effectiveness. Early diagnosis and treatment were crucial to prevent permanent hair loss and psychological effects.
